By considering IRAK1-positive cells, irrespective of the phenotype, the immunofluorescence analysis showed an increased percentage of these cells in the thymus of corticosteroid-naïve MG patients compared to control thymuses (Figure 3B). This evidence concerns the gene IRAK1 and myasthenia gravis.